Author(s): N. N. Gavrilova, I.A. Ratnikova, A. K. Sadanov, S. E. Orazymbet, E. Zh. Shorabaev, L. E. Protasiuk
DOI: 10.52711/0974-360X.2023.00670
Views:
14
(pdf),
1589
(html)
Access:
Open Access
Cite: N. N. Gavrilova, I.A. Ratnikova, A. K. Sadanov, S. E. Orazymbet, E. Zh. Shorabaev, L. E. Protasiuk. Development of Technology for the production of finished forms of Medicinal probiotics. Research Journal of Pharmacy and Technology 2023; 16(9):4093-4. doi: 10.52711/0974-360X.2023.00670
Read More
|
Author(s): N.N. Gavrilova, I.A. Ratnikova, A.K. Sadanov, S.E. Orazymbet, E.Zh. Shorabaev, B.B. Baimakhanova, L.E. Protasiuk
DOI: 10.52711/0974-360X.2023.00682
Views:
12
(pdf),
1432
(html)
Access:
Open Access
Cite: N.N. Gavrilova, I.A. Ratnikova, A.K. Sadanov, S.E. Orazymbet, E.Zh. Shorabaev, B.B. Baimakhanova, L.E. Protasiuk. Determination of the Toxicity and Sensitizing effect of a Therapeutic Probiotic agent against Intestinal and Concomitant human infections. Research Journal of Pharmacy and Technology 2023; 16(9):4161-1. doi: 10.52711/0974-360X.2023.00682
Read More
|
Author(s): A.K. Sadanov, I.R. Kulmagambetov, F.N. Nurmanbetova, G. Zh. Sarsenbayeva, I.A. Ratnikova, S.Orazymbet, Ye.Zh. Shorabayev, B.B. Baimakhanova, L.Ye. Protasyuk, A.D. Massirbayeva
DOI: 10.52711/0974-360X.2024.00613
Views:
18
(pdf),
1212
(html)
Access:
Open Access
Cite: A.K. Sadanov, I.R. Kulmagambetov, F.N. Nurmanbetova, G. Zh. Sarsenbayeva, I.A. Ratnikova, S.Orazymbet, Ye.Zh. Shorabayev, B.B. Baimakhanova, L.Ye. Protasyuk, A.D. Massirbayeva. First Phase of the Clinical trial of the AS-Probionorm Probiotic Medication for the treatment of Human Intestinal Infections. 2024; 17(8):39498-4. doi: 10.52711/0974-360X.2024.00613
Read More
|
Author(s): A.K. Sadanov, I.A. Ratnikova, S.E. Orasymbet, Ye.Zh. Shorabayev, B.B. Baymakhanova, L.Ye. Protasyuk, A.D. Massirbayeva
DOI: 10.52711/0974-360X.2024.00904
Views:
6
(pdf),
1121
(html)
Access:
Open Access
Cite: A.K. Sadanov, I.A. Ratnikova, S.E. Orasymbet, Ye.Zh. Shorabayev, B.B. Baymakhanova, L.Ye. Protasyuk, A.D. Massirbayeva. Developing Safe Probiotic Solutions for the Treatment of Human Intestinal Infections. Research Journal Pharmacy and Technology. 2024;17(12):5960-6. doi: 10.52711/0974-360X.2024.00904
Read More
|
Author(s): A.K. Sadanov, B.B. Baymakhanova, I.A. Ratnikova, S.E. Orazymbet, L.Ye. Protasyuk, A.D. Massirbaeva, A.S. Balgimbayeva, L.P. Trenozhnikova, G.B. Baymakhanova, A. Amangeldy, A. Omirbekova
DOI: 10.52711/0974-360X.2025.00245
Views:
0
(pdf),
733
(html)
Access:
Closed Access
Cite: A.K. Sadanov, B.B. Baymakhanova, I.A. Ratnikova, S.E. Orazymbet, L.Ye. Protasyuk, A.D. Massirbaeva, A.S. Balgimbayeva, L.P. Trenozhnikova, G.B. Baymakhanova, A. Amangeldy, A. Omirbekova. Active Pharmaceutical Substance Production Technology using Lactobacillus fermentum and Lactobacillus cellobiosus for the treatment of Intestinal Infections. Research Journal of Pharmacy and Technology. 2025;18(4):1709-7. doi: 10.52711/0974-360X.2025.00245
Read More
|